% | $
Quotes you view appear here for quick access.

công ty Questcor Pharmaceuticals Message Board

  • ms1184 ms1184 Jul 11, 2013 7:04 AM Flag


    6:31AM Questcor Pharma to initiate pilot commercialization effort in pulmonology for symptomatic sarcoidosis (QCOR) 47.20 : Co announced its intent to initiate a pilot commercialization effort for H.P. Acthar Gel (repository corticotropin injection) for the treatment of respiratory manifestations of symptomatic sarcoidosis, a potentially serious, difficult-to-treat disorder already included on the FDA-approved package insert for Acthar. The pilot effort will focus on pulmonologists. The co is also evaluating several potential clinical studies that have been recently proposed by key opinion leaders in the sarcoidosis field.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies